Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Schizophrenia and anorexia nervosa were recently added to the list of conditions for which whole genome sequencing might be indicated as part of the 100 000 Genomes Project, reflecting the remarkable recent progress in findings emerging from psychiatric genetics research. Genetic testing methods may offer increased opportunities for diagnosis and estimation of familial risk and could have implications for management and treatment options. They also present ethical and philosophical questions about the role of testing and storage of genetic information. Mental health professionals will need to have a good understanding of this area in order for patients to fully realise the benefits of these advances.Declaration of InterestK.S.B. is Editor of the British Journal of Psychiatry.

Original publication

DOI

10.1192/bjp.2019.48

Type

Journal article

Journal

Br J Psychiatry

Publication Date

05/2019

Volume

214

Pages

248 - 250

Keywords

Genetics, anorexia nervosa, schizophrenia, Genetic Predisposition to Disease, Genetic Testing, Humans, Mental Disorders, State Medicine, United Kingdom, Whole Genome Sequencing